Impact and Implementation: Alere's VP for Regulatory Affairs on the US FDA Unique Device Identification System
Ahead of the UDIs and Traceability for Medical Devices Forum 2014, Simon Richards, VP for Regulatory Affairs, EME at Alere, joins Andrea Charles from Pharma IQ to discuss the benefits of a well-built unique device identification (UDI) system, developing a strategy for implementation and future perspectives for medical device manufacturers.
Pharma IQ: What impact is the US FDA Unique Device Identification System Final Rule having on your company?
S Richards: It is having a very great effec...
To continue reading this story get free access